Clincosm LogoSign in Get a demo

Hypertension

Showing NaN - NaN of 91
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypertension Trial in Worldwide (Olmesartan, Amlodipine, Indapamide)

Recruiting
  • Hypertension
  • Birmingham, Alabama
  • +119 more
Jan 13, 2023

Hypertension Trial in United States (Anti-hypertensive therapy, No anti-hypertensive therapy (unless BP is severe))

Completed
  • Hypertension
  • Anti-hypertensive therapy
  • No anti-hypertensive therapy (unless BP is severe)
  • Birmingham, Alabama
  • +71 more
Dec 16, 2022

Hypertension Trial in Worldwide (Placebo, ALN-AGT01)

Recruiting
  • Hypertension
  • Birmingham, Alabama
  • +112 more
Dec 16, 2022

Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in Dallas (Angiotensin II Receptor Blockers

Recruiting
  • Cognitively Normal Older Adults
  • +3 more
  • Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)
  • PCP
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Dec 1, 2022

Hypertension, Vascular Diseases, Cardiovascular Diseases Trial in Worldwide (Renal Denervation (Symplicity Spyral™))

Active, not recruiting
  • Hypertension
  • +2 more
  • Renal Denervation (Symplicity Spyral™)
  • Stanford, California
  • +8 more
Oct 21, 2022

Dose-Response to Exercise in Women Aged 45-75 Years (DREW)

Completed
  • Cardiovascular Diseases
  • +3 more
  • Exercise
  • Dallas, Texas
  • +1 more
Sep 13, 2022

Cognitive Decline, Blood Pressure, Hypertension Trial in Dallas (Clinical Support Decision Tool)

Recruiting
  • Cognitive Decline
  • +2 more
  • Clinical Support Decision Tool
  • Dallas, Texas
    UT Southwestern Medical Center
Aug 29, 2022

Hypertension, Type 2 Diabetes Trial in Dallas (Home visit)

Recruiting
  • Hypertension
  • Type 2 Diabetes
  • Home visit
  • Dallas, Texas
    UT Southwestern Medical Center
Aug 23, 2022

Hypertension Trial in Dallas (Standard Care, Intensive Treatment)

Active, not recruiting
  • Hypertension
  • Standard Care
  • Intensive Treatment
  • Dallas, Texas
    UT Southwestern Medical Center
Aug 11, 2022

Hypertension, Obesity Trial in Dallas (Neuropeptide Y)

Recruiting
  • Hypertension
  • Obesity
  • Neuropeptide Y
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Aug 8, 2022

Hypertension Trial in Dallas (KMgCit, Placebo)

Not yet recruiting
  • Hypertension
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jul 26, 2022

Hypertension Trial in United States (Dehydrated alcohol, Peregrine System Kit (Sham Procedure))

Recruiting
  • Hypertension
  • Dehydrated alcohol
  • Peregrine System Kit (Sham Procedure)
  • Birmingham, Alabama
  • +4 more
Jun 8, 2022

Therapeutic Drug Monitoring of Cardiac Medications

Recruiting
  • Hypertension
  • Coronary Artery Disease
  • Therapeutic drug monitoring
  • Dallas, Texas
    UT Southwestern
May 10, 2022

Hypertension Trial in Dallas (DEFINITY® infusion, Human Recombinant Regular Insulin infusion, Dextrose infusion)

Recruiting
  • Hypertension
  • DEFINITY® infusion
  • +6 more
  • Dallas, Texas
    UT Southwestern Medical Center
Mar 22, 2022

Hypertension Trial in Dallas (Eplerenone, Amlodipine, Microneurography)

Completed
Has Results
  • Hypertension
  • Dallas, Texas
    UT Southwestern Medical Center
Feb 22, 2022

Multi-Gene Panel and Renal Denervation Effectiveness in

Recruiting
  • Hypertension
  • Geneticure for RDN Genetic Panel
  • Dallas, Texas
    Baylor Scott and White Health
Feb 1, 2022

Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in United States (drug, behavioral, other)

Completed
  • Cognitively Normal Older Adults
  • +3 more
  • Angiotensin II receptor blocker (ARB, losartan) and calcium channel blocker (CCB, amlodipine)
  • +3 more
  • Kansas City, Kansas
  • +3 more
Feb 12, 2022

Hypertension Trial in Dallas (Potassium Magnesium Citrate (KMgCit), Potassium Chloride (KCl), Chlorthalidone)

Recruiting
  • Hypertension
  • Potassium Magnesium Citrate (KMgCit)
  • +2 more
  • Dallas, Texas
  • +2 more
Feb 10, 2022

End Stage Renal Disease, Hypertension, Extracellular Volume Overload Trial in Dallas (IBPS-Guided Ultrafiltration)

Recruiting
  • End Stage Renal Disease
  • +3 more
  • IBPS-Guided Ultrafiltration
  • Dallas, Texas
    VA North Texas Health Care System Dallas VA Medical Center, Dall
Jan 21, 2022

Hypertension, African Americans, Diet, Carbohydrate-Restricted Trial in Dallas (Very low carbohydrate diet, Standard DPP-GLB

Active, not recruiting
  • Hypertension
  • +3 more
  • Very low carbohydrate diet
  • +2 more
  • Dallas, Texas
    Baylor Research Institute
Dec 16, 2021

Hypertension Trial in Dallas (High Phosphate Phase, Low Phosphate Phase)

Recruiting
  • Hypertension
  • High Phosphate Phase
  • Low Phosphate Phase
  • Dallas, Texas
  • +2 more
Oct 28, 2021

Diabetes, Hypertension, Chronic Kidney Diseases Trial in Dallas (Usual Care, I-POP + CHW navigation)

Recruiting
  • Diabetes
  • +4 more
  • Usual Care
  • I-POP + CHW navigation
  • Dallas, Texas
    Baylor Research Institute
Jul 22, 2021

Hypertension Trial in Iceland, United States (LCI699, Eplerenone, LCI699-matching Placebo)

Completed
Has Results
  • Hypertension
  • Mobile, Alabama
  • +37 more
May 6, 2021

Hypertension Trial in United States (Renal Denervation (Vessix), Renal Angiography)

Completed
Has Results
  • Hypertension
  • Renal Denervation (Vessix)
  • Renal Angiography
  • Birmingham, Alabama
  • +11 more
Jan 25, 2021

Dyslipidemia, Hypertension Trial in United States (Amlodipine besylate, Amlodipine besylate/atorvastatin calcium single pill

Completed
Has Results
  • Dyslipidemia
  • Hypertension
  • Amlodipine besylate
  • Amlodipine besylate/atorvastatin calcium single pill combination
  • Birmingham, Alabama
  • +50 more
Jan 26, 2021